U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609875) titled 'A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild Hypertension' on May 11.
Brief Summary: The purpose of this study is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple oral doses of HS-10522 in healthy Chinese participants and Chinese participants with mild hypertension.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Hypertension
Intervention:
DRUG: HS-10522
HS-10522 tablet, oral, single ascending dose a...